Advanced NanoTherapies
PrivateLast Round
Series B
Jun 2, 2026
Total Funding Raised
$47.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Advanced NanoTherapies operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Series B round in June 2026.
Advanced NanoTherapies is a clinical-stage medical technology company developing a nanoparticle drug delivery platform for catheter-based interventions to treat coronary and peripheral artery disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Advanced NanoTherapies Comparables
Compare Advanced NanoTherapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encompass Vascular, Inc. | 84% | |
| Concept Medical Inc. | 81% | |
| Orchestra BioMed Holdings, Inc. | 79% |
For institutional investors. Book with your work email.
Advanced NanoTherapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2026 | ||||
| Series A Extension | Aug 22, 2023 | ||||
| Series A | Jun 28, 2022 | ||||
| Seed | Oct 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Advanced NanoTherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ForMED Ventures | Seed |
| S3 Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Aug 17, 2026
Grew 38% QoQ, from 16 to 22 employees.
For institutional investors. Book with your work email.
Advanced NanoTherapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Advanced NanoTherapies's valuation, stock price, and market status.
Is Advanced NanoTherapies a public or private company?
Advanced NanoTherapies is a private company.
What is the current stock price of Advanced NanoTherapies?
Advanced NanoTherapies is a private company, so its shares have no public market price. Caplight tracks Advanced NanoTherapies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Advanced NanoTherapies worth (valuation)?
Valuation information for Advanced NanoTherapies is not publicly available.
Can I buy Advanced NanoTherapies stock?
Advanced NanoTherapies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Advanced NanoTherapies's last funding round?
Advanced NanoTherapies's most recent funding round was Series B on June 2, 2026.
Who are the main investors in Advanced NanoTherapies?
Key investors in Advanced NanoTherapies include S3 Ventures.
Will Advanced NanoTherapies IPO soon?
No public IPO plans have been announced for Advanced NanoTherapies.
How can I track Advanced NanoTherapies secondary market activity?
Caplight tracks bids, offers, and trades in Advanced NanoTherapies's shares on secondary markets.